CelluVir Biotechnology is on a mission to enhance global health by creating accessible and user-friendly diagnostic solutions. Specializing in assessing antiviral cellular immunity, our innovative Skin patch technology offers a non-invasive and painless way to test immunity against viruses, including our unique SARS-CoV-2 test. This revolutionary diagnostic tool helps determine the necessity for vaccinations or treatment, thus addressing the pressing issue of managing viral diseases like never before.

With a focus on personalized approaches, our team strives to provide affordable solutions that are crucial in combating global health threats. The CoviCell Skin patch, developed with the support of esteemed institutes such as Semmelweis University and the National Korányi Institute of Pulmonology, is at the forefront of our efforts to revolutionize antiviral immunity assessment. Trust CelluVir for reliable, efficient, and effective diagnostic tools that put global health first.